These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 4289605)

  • 21. Increase of glycogen and oligosaccharide contents in ascites tumor cells under the influence of alkylating agents.
    Tashiro T; Sakurai Y
    Gan; 1969 Aug; 60(4):465-8. PubMed ID: 4310237
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of compounds on a spectrum of rat tumors.
    Sugiura K; Schmid FA; Schmid MM; Brown GF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):231-308. PubMed ID: 4350013
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro test for prediction of side effects of carcinostatic agents.
    Kondo T; Ohkubo K
    Gan; 1967 Aug; 58(4):349-54. PubMed ID: 6079791
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the problem of the effectiveness of d-glyceraldehyde].
    Brock N; Niekamp T
    Z Krebsforsch; 1965 Jul; 67(1):93-104. PubMed ID: 4221137
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies with Proresid (SP-I) in various innoculation tumors].
    Osswald H; Schmähl D
    Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of DBM on rat ascites tumors and antibody production.
    Irikura T; Kawasaki H; Enta R; Hasegawa Y
    Chem Pharm Bull (Tokyo); 1970 Feb; 18(2):394-6. PubMed ID: 4314621
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of transplantable tumour cells by tetanus spores.
    Schneeweiss U; Fabricius EM
    Arch Geschwulstforsch; 1970; 35(1):1-5. PubMed ID: 4327129
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of various carcinostatic agents on acridine orange uptake by Ehrlich ascites carcinoma cells.
    Hano K; Iwata H; Morita S
    Gan; 1966 Feb; 57(1):19-26. PubMed ID: 4959535
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

  • 30. IN VITRO CULTURE OF YOSHIDA SARCOMA CELLS: METHODS FOR DETERMINING ACQUIRED RESISTANCE TO DRUGS.
    SAKURAI Y
    Natl Cancer Inst Monogr; 1964 Dec; 16():207-39. PubMed ID: 14235655
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours.
    Kellner B; Németh L; Sugár J; Gáti E; Pályi I; Döbrössy L
    Arzneimittelforschung; 1967 Aug; 17(8):1037-43. PubMed ID: 5244384
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
    Institóris L; Horváth IP; Csányi E
    Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481
    [No Abstract]   [Full Text] [Related]  

  • 33. Iyomycin, a new antitumor antibiotic from Streptomyces. IV. Experimental treatment of malignant tumors with iyomycins.
    Hoshino M; Umezawa I; Mimura Y; Hata T
    J Antibiot (Tokyo); 1967 Jan; 20(1):20-40. PubMed ID: 6072279
    [No Abstract]   [Full Text] [Related]  

  • 34. Antitumor activity of DL-1-beta-chloroethyl-2-chloromethylpiperidine hydrobromide (CAP-1) on some rodent tumors.
    Koshiura R; Kato H; Mori T
    Jpn J Pharmacol; 1973 Aug; 23(4):535-41. PubMed ID: 4356998
    [No Abstract]   [Full Text] [Related]  

  • 35. [Toxicity and antineoplastic activity of a new thio-TEPA analog].
    Konovalova NP; D'iachkovskaia RF; Kiseleva EG
    Vopr Onkol; 1973; 19(1):58-63. PubMed ID: 4349733
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental study on drug sensitivity of the rat ascites hepatoma cells in embryonated eggs.
    Terui S
    Sci Rep Res Inst Tohoku Univ Med; 1975 Jul; 22(1-2):10-7. PubMed ID: 171765
    [No Abstract]   [Full Text] [Related]  

  • 37. 2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256.
    Cobb LM; Connors TA; Elson LA; Khan AH; Mitchley BC; Ross WC; Whisson ME
    Biochem Pharmacol; 1969 Jun; 18(6):1519-27. PubMed ID: 4307990
    [No Abstract]   [Full Text] [Related]  

  • 38. [Remarkable antimitotic action of watercress (Nasturtium officinales) on some experimental tumors].
    Cruz A
    Hospital (Rio J); 1970 Mar; 77(3):943-52. PubMed ID: 5315123
    [No Abstract]   [Full Text] [Related]  

  • 39. Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune.
    Komatsu N; Okubo S; Kikumoto S; Kimura K; Saito G
    Gan; 1969 Apr; 60(2):137-44. PubMed ID: 5810959
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental anc clinical studies on the sensitivity test for carcinostatic agent from the cytological point of view].
    Chang YS
    Bull Chest Dis Res Inst Kyoto Univ; 1972 Jan; 5(1):1-17. PubMed ID: 4638387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.